Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a fatty liver disease related to metabolic causes, alcohol use, or a combination of both (known by terms such as MASLD, ALD, or MetALD)
- People who have had a liver biopsy within the last 2 months, or who have one planned, either to confirm cirrhosis (scarring of the liver) without liver cancer (the "Control" group), or to confirm liver cancer on a cirrhotic liver (the "Case" group)
- People who are covered by a social security or health insurance scheme in the relevant country
- People who have read, understood, and signed a consent form agreeing to take part in the study, which involves the collection of biological samples
Who may not be able to join:
- People whose liver disease is caused by something other than the conditions listed above (for example, viral hepatitis or autoimmune liver disease)
- People who have had a serious liver-related complication in the two years before joining the study, such as fluid build-up in the abdomen, confusion caused by liver failure, bleeding from swollen veins in the digestive tract, liver failure, or kidney failure related to liver disease
- People in the "Control" group who have a previous history of liver cancer
- People who are currently pregnant, breastfeeding, or in labour
- People who are currently detained or imprisoned by a legal or government decision
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jérôme BOURSIER, Professor, University Hospital, Angers
Phone: +33 (0)2 41 35 64 28
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Blood sample for biocollection; Urinary sample for biocollection; faecal sample for biocollection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.